In November 23, 2016, Dr. Lishan Zhao, who was engaged in the more than 20 year research on the biosynthesis of anticancer drugs at Silicon Valley in the United States, visited our Harvar headquarters in China and the Harvar Institute in Guangdong. Both sides have conducted in-depth and comprehensive discussions on the biosynthesis of astaxanthin, and co built cancer prevention and development on both sides. The lab reached a preliminary cooperation agreement and was pleased to be appointed honorary academician of Guangdong Harvar Institute. Dr. Zhao pays tribute to our company's courage in pursuit of great and noble dreams.
